Genetic aspects of heart failure

European Journal of Heart Failure

Volumn 1, Issue 2, 1999, Pages 121-126

  Komajda, Michel ^a   Charron, Philippe ^a   Tesson, Frédérique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Dilated cardiomyopathy; Genetics; Heart failure; Hypertrophic cardiomyopathy; Left ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEREDITY; HUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CARDIOMYOPATHY, HYPERTROPHIC; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MUTATION; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0033505455     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00026-4     Document Type: Review

References (47)

1. Levy D., Garrison R., Savage D., Kannel W., Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
2. Adams T.D., Yanowitz F.G., Fisher A.G., Adams T.D., Yanowitz F.G., Fisher A.G., Ridges J.D., Nelson A.G., Hagan A.D., Williams R.R., Hunt S.C. Heritability of cardiac size: an echocardiographic andelectrocardiographic study of monozygotic and dizygotic twins. Circulation. 71:1985;39-44.
3. Verhaaren H.A., Schieken R.M., Mosteller M., Hewitt J.K., Eaves L.J., Nance W.E. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol. 68:1991;661-668.
4. Schunkert H., Hense H.W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., Riegger G.A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl J Med. 330:1994;1634-1638.
5. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variace of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
6. Lindpaintner K., Lee M., Larson M.G., Rao V.S., Pfeffer M.A., Ordovas J.M., Schaefer E.J., Wilson A.F., Wilson P.W., Vasan R.S., Myers R.H., Levy D. Absence of association of genetic linkage between the angiotensin converting-enzyme gene and left ventricular mass. N Engl J Med. 334:1996;1023-1028.
7. Montgomery H.E., Clarkson P., Dollery C.M., Prasad K., Losi M.A., Hemingway H., Statters D., Jubb M., Girvain M., Varnava A., World M., Deanfield J., Talmud P., McEwan J.R., Mc Kenna W.J., Humphries S. Association of the angiotensin converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 96:1997;741-747.
8. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Brynes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., Humphries S.E. Human gene for physical performance. Nature. 393:1998;221-222.
9. Wong K.K., Summers K.M., Burstow D.J., West M.J. Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy. Clin Exp Pharmacol Physiol. 23:1996;587-590.
10. Hernandez D., Lacalzada J., Rufino M., Torres A., Martin N., Barragan A., Barrios Y., Macia M., de Bonis E., Lorenzo V., Rodriguez A., Gonzalez-Posada J.M., Salido E. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene. Kidney Int. 51:1997;1205-1211.
11. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 92:1995;785-789.
12. Maron B.J., Nichols III P.F., Pickle L.W., Wesley Y.E., Mulvihill J.J. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol. 53:1984;1087-1094.
13. Bonne G., Carrier L., Richard P., Hainque B., Schwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res. 83:1998;580-593.
14. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W., Seidman C.E., Seidman J.G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 326:1992;1108-1114.
15. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A., Spirito P., Matsumori A., Moravec C.S., Seidman J.G. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 332:1995;1058-1064.
16. Charron P., Dubourg O., Desnos M., Isnard R., Hagege A., Bonne G., Carrier L., Tesson F., Bouhour J.B., Buzzi J.C., Feingold J., Schwartz K., Komajda M. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J. 19:1998;139-145.
17. Nimura H., Bachinski L., Sangwatanaroj S., Watkins H., Chudley E.A., McKenna M.J., Kristinsson A., Roberts R., Sole M., Maron B.J., Seidman J.G., Seidman C.E. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 338:1998;1248-1257.
18. Fananapazir L., Epstein N.D. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation. 89:1994;22-32.
19. Anan R., Shono H., Kisanuki A., Arima S., Nakao S., Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation. 98:1998;391-397.
20. Forissier J.F., Carrier L., Farza H., Bonne G., Bercovici J., Richard P., Hainque B., Townsend P.J., Yacoub M.H., Faure S., Dubourg O., Millaire A., Hagege A.A., Desnos M., Komajda M., Schwartz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation. 94:1996;3069-3073.
21. Lechin M., Quinones M.A., Omran A., Hill R., Yu Q.T., Rakowski H., Wigle D., Liew C.C., Sole M., Roberts R. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
22. Marian A.J., Yu Q.T., Workman R., Greve G., Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 342:1993;1085-1086.
23. Tesson F., Dufour C., Moolman J.C., Carrier L., al-Mahdawi S., Chojnowska L., Dubourg O., Soubrier E., Brink P., Komajda M., Guicheney P., Schwartz K., Feingold J. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol. 29:1997;831-838.
24. Brugada R., Kelsey W., Lechin M., Zhao G., Yu Q.T., Zoghbi W., Quinones M., Elstein E., Omran A., Rakowski H., Wigle D., Liew C.C., Sole M., Roberts R., Marian A.J. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med. 45:1997;542-551.
25. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W.T., Lowes B.D., Zisman L.S., Taft C.S., Perryman M.B. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
26. Montgomery H.E., Keeling P.J., Goldman J.H., Humphries S.E., Talmud P.J., McKenna W.J. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 25:1995;1627-1631.
27. Andersson B., Sylvén C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 28:1996;162-167.
28. Pinto Y.M., van Gilst W.H., Kingma J.H., Schunkert H. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol. 25:1995;1622-1626.
29. Keeling P.J., Gang Y., Smith G., Seo H., Bent S.E., Murday V., Caforio A.L.P., McKenna W.J. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 73:1995;417-421.
30. Grünig E., Tasman J.A., Kücherer H., Franz W., Kübler W., Katus H.A. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 31:1998;186-194.
31. Mestroni L. Dilated cardiomyopathy: a genetic approach. Heart. 77:1997;185-188.
32. Baig M.K., Goldman J.H., Caforio A.L., Coonar A.S., Keeling P.J., McKenna W.J. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol. 31:1998;195-201.
33. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.-S., Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 280:1998;750-752.
34. Krajinovic M., Pinamonti B., Sinagra G., Vatta M., Severini G.M., Milasin J., Falaschi A., Camerini F., Giacca M., Mestroni L. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet. 57:1995;846-852. the Heart Muscle Disease Study Group.
35. Durand J.B., Bachinski L.L., Bieling L.C., Czernuszewicz G.Z., Abchee A.B., Yu Q.T., Tapscott T., Hill R., Ifegwu J., Marian A.J., Brugada R., Daiger S., Gregoritch J.M., Anderson J.L., Quinones M., Towbin J.A., Roberts R. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 92:1995;3387-3389.
36. Kass S., MacRae C., Graber H.L., Sparks E.A., McNamara D., Boudoulas H., Basson C.T., Baker III P.B., Cody R.J., Fishman M.C., Cox N., Kong A., Wooley C.F., Seidman J.G., Seidman C.E. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet. 7:1994;546-551.
37. Olson T.M., Keating M.T. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 97:1996;528-532.
38. Bowles K.R., Gajarski R., Porter P., Goytia V., Bachinski L., Roberts R., Pignatelli R., Towbin J.A. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 98:1996;1355-1360.
39. Messina D.N., Speer M.C., Pericak-Vance M.A., McNally E.M. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 61:1997;909-917.
40. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., Marrosu M.G., Cianchetti C., Realdi G., Cao A., Melis M.A. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 329:1993;921-925.
41. Yoshida K., Ikeda S., Nakamura A., Kagoshima M., Takeda S., Shoji S., Yanagisawa N. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve. 16:1993;1161-1166.
42. Bies R.D., Maeda M., Roberds S.L., Holder E., Bohlmeyer T., Young J.B., Campbell K.P. A 5′ dystrophin duplication mutation causes membrane deficiency of a-dystroglycan in a family with X-linked cardiomyopathy. J Mol Cell Cardiol. 29:1997;3175-3188.
43. Milasin J., Muntoni F., Severini G.M., Bartoloni L., Vatta M., Krajinovic M., Mateddu A., Angelini C., Camerini F., Falaschi A., Mestroni L., Giacca M., Pinamonti B., Sinagra G., Dilenarda A., Silvestri F., Bussani R., Davanzo M. A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Molec Genet. 5:1996;73-79.
44. Ortiz-Lopez R., Li H., Su J., Goytia V., Towbin J.A. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95:1997;2434-2440.
45. Muntoni F., Lenarda A.D., Porcu M., Sinagra G., Mateddu A., Marrosu G., Ferlini A., Cau M., Milasin J., Melis M.A., Marrosu M.G., Cianchetti C., Sanna A., Falaschi A., Camerini F., Giacca M., Mestroni L. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart. 78:1997;608-612.
46. Melis M.A., Cau M., Deidda F., Gatti R., Mateddu A., Marrosu G., Muntoni F. Mutations of dystrophin gene in two families with X-linked dilated cardiomyopathy. Neuromuscul Disord. 8:1998;244.
47. Politano L., Passamano L., Petretta V.R., Nigro V., Papparella S., Santangelo L., Nigro G.e, Esposito M.G., Luca F.D., Nigro G. Familial dilated cardiomyopathy in two brothers with dystrophin gene anomalies. Neuromuscular Disord. 8:1998;245.